| Gene symbol | IL2 | Synonyms | IL-2, TCGF, lymphokine | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4q27 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | interleukin 2 | ||||
| GTO ID | GTC1148 |
| Trial ID | NCT00002748 |
| Disease | Neuroblastoma |
| Altered gene | IL-2 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | IL-2 RV tumor cells |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Phase I Study of Cytokine-Gene Modified Autologous or Partially Matched Allogeneic Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma |
| Year | 2004 |
| Country | United States |
| Company sponsor | St. Jude Children's Research Hospital |
| Other ID(s) | CDR0000064681|U01CA058211|P30CA021765|SJCRH-CYGENE|SJCRH-CYGNE2|NCI-H96-0005 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||